In the present study, TB-IRIS occurred in 9% of the patients, despite the rather short time interval between the initiation of antituberculous drugs and ART and the low baseline CD4 count, two recognised risk factors [23], [26]–[28]. This evidence concerns the gene CD4 and tuberculosis.